Biofrontera Inc.
BFRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 9.5% | 18.8% | 19% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 50.1% | 48.8% | 47% | 47.1% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -38.7% | -54.2% | 3.3% | -152.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -47.6% | -59.1% | -2.2% | -156.5% |
| EPS Diluted | -3.22 | -13.02 | -0.61 | -44.1 |
| % Growth | 75.3% | -2,034.4% | 98.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |